Predicting stroke risk based on health behaviours: Development of the Stroke Population Risk Tool (SPoRT)

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Manuel, Douglas G ^a,b,c,d,e,f   Tuna, Meltem ^a,b   Perez, Richard ^a,b   Tanuseputro, Peter ^b,e   Hennessy, Deirdre ^a,c   Bennett, Carol ^a,b   Rosella, Laura ^b,g,h   Sanmartin, Claudia ^c   Van Walraven, Carl ^a,b,e   Tu, Jack V ^b,h,i  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c STATISTICS CANADA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f BRUYÈRE RESEARCH INSTITUTE   (Canada)

^g PUBLIC HEALTH ONTARIO   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; BODY MASS; CANADA; CANADIAN; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH BEHAVIOR; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMIGRATION; INCIDENCE; INCOME; ISCHEMIC HEART DISEASE; MALE; NEIGHBORHOOD; PHYSICAL ACTIVITY; POPULATION RESEARCH; RISK ASSESSMENT; SEX; SMOKING; STRESS; STROKE POPULATION RISK TOOL; COMPLICATION; MIDDLE AGED; ONTARIO; PROCEDURES; SELF REPORT; STROKE; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FEMALE; HEALTH BEHAVIOR; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; ONTARIO; RISK ASSESSMENT; SELF REPORT; STROKE; YOUNG ADULT;

EID: 84956651210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143342     Document Type: Article

References (50)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012, 380(9859):2095-2128.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012, 380(9859):2224-2260.
3. Manuel DG. The effectiveness of national guidelines for preventing cardiovascular disease: integrating effectiveness concepts and evaluating guidelines' use in the real world. Curr Opin Lipidol 2010, 21(4):359-365. PMID: 20581675
4. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW et al: Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 2010, 170(1):27-40. doi: 10.1001/archinternmed.2009.434PMID: 20065196
5. Manuel DG, Rosella LC, Hennessy D, Sanmartin C, Wilson K. Predictive risk algorithms in a population setting: an overview. J Epidemiol Community Health 2012, 66:859-865. doi: 10.1136/jech-2012-200971PMID: 22859516
6. Rose G. Rose's Strategy of Preventive Medicine. Oxford: Oxford University Press; 2008.
7. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A et al: Revisiting Rose: strategies for reducing coronary heart disease. British Medical Journal 2006, 332(7542):659-662. PMID: 16543339
8. Rosella LC, Manuel DG, Burchill C, Stukel TA, PHIAT-DM team: A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health 2011, 65(7):613-620. doi: 10.1136/jech.2009.102244PMID: 20515896
9. Chiuve SE, Cook NR, Shay CM, Rexrode KM, Albert CM, Manson JE et al. Lifestyle-Based Prediction Model for the Prevention of CVD: The Healthy Heart Score. Journal of the American Heart Association 2014, 3(6).
10. Rabar S, Harker M, O'Flynn N, Wierzbicki AS, Guideline Development Group: Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ 2014, 349:g4356. doi: 10.1136/bmj.g4356PMID: 25035388
11. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB et al: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7aPMID: 24222016
12. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R et al: Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007, 370(9604):2054-2062. PMID: 18063025
13. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman L, Magnus A et al: Assessing Cost-Effectiveness in Prevention. The University of Queensland, Brisbane, and Deakin University, Melbourne 2010.
14. Schulte JM, Rothaus CS, Adler JN. Starting Statins - Polling Results. New England Journal of Medicine 2014, 371(4):e6. doi: 10.1056/NEJMclde1407177
15. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE et al: The effect of giving global coronary risk information to adults: a systematic review. Archives of internal medicine 2010, 170(3):230. doi: 10.1001/archinternmed.2009.516PMID: 20142567
16. Beland Y. Canadian Community Health Survey - Methodological Overview. Health Reports 2002, 13(2):9-14.
17. Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005, 36(8):1776-1781.
18. Tu K, Wang M, Young J, Green D, Ivers NM, Butt D et al: Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard. Can J Cardiol 2013, 29(11):1388-1394. doi: 10.1016/j.cjca.2013.07.676PMID: 24075778
19. CSS Information & Evaluation Working Group: Canadian Stroke Strategy Core Preformance Indicator Update 2010. In: Candain Stroke Network. 2010: 1-7.
20. Pintilie M. Dealing with competing risks: testing covariates and calculating sample size. Stat Med 2002, 21(22):3317-3324. PMID: 12407674
21. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18(6):695-706. PMID: 10204198
22. Pencina MJ, D'Agostino RB Sr., Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009, 119(24):3078-3084. doi: 10.1161/CIRCULATIONAHA.108.816694PMID: 19506114
23. Nardo M, Saisana M, Saltelli A, Tarantola S, Hoffman A, Giovannini E. Handbook on constructing composite indicators: methodology and user guide. In.: OECD publishing; 2005.
24. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 2010, 376(9754):1775-1784.
25. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao P et al: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet 2010, 376(9735):112-123.
26. Schisterman EF, Cole SR, Platt RW: Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009, 20(4):488-495. PMID: 19525685
27. Bansal A, Pepe MS. When does combining markers improve classification performance and what are implications for practice?Stat Med 2013, 32(11):1877-1892. doi: 10.1002/sim.5736PMID: 23348801
28. Dalton AR, Bottle A, Soljak M, Okoro C, Majeed A, Millett C. The comparison of cardiovascular risk scores using two methods of substituting missing risk factor data in patient medical records. Informatics in primary care 2011, 19(4):225-232. PMID: 22828577
29. Diamond GA. Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction. Journal of the American College of Cardiology 1989, 14(3 Suppl A):12A-22A. PMID: 2768728
30. Tripepi G, Jager KJ, Dekker FW, Zoccali C. Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification. Nephrol Dial Transplant 2010, 25(5).
31. Manuel D, Maaten S, Rosella L, Wilson S, Ho T. Modelling potential impact of interventions for diabetes prevention, early detection and management: final report. In: ICES Investigative Report. Toronto: Institute for Clinical Evaluative Sciences; 2008.
32. Concordance for survival time data: fixed and time-dependent covariates and possible ties in predictor and time [http://cancercenter.mayo.edu/mayo/research/biostat/upload/80.pdf]
33. Bouwmeester W, Zuithoff NP, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW et al. Reporting and methods in clinical prediction research: a systematic review. PLoS Med 2012, 9(5):1-12.
34. World Health Organization: Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk: World Health Organization; 2007.
35. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L et al: Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond. Circulation 2010, 121(4):586-613. doi: 10.1161/CIRCULATIONAHA.109.192703PMID: 20089546
36. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. London: Springer; 2009.
37. Qiao Q, Gao W, Laatikainen T, Vartiainen E. Layperson-oriented vs. clinical-based models for prediction of incidence of ischemic stroke: National FINRISK Study. International journal of stroke: official journal of the International Stroke Society 2012, 7(8):662-668.
38. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. The Lancet 2008, 371(9616):923-931.
39. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011, 343:d7163. doi: 10.1136/bmj.d7163PMID: 22123912
40. Muggah E, Graves E, Bennett C, Manuel DG. Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report. BMC Public Health 2013, 13(16).
41. Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la sante / Statistique Canada, Centre canadien d'information sur la sante 2012, 23(1):47-53.
42. Shields M, Connor Gorber S, Tremblay MS. Estimates of obesity based on self-report versus direct measures. Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la sante / Statistique Canada, Centre canadien d'information sur la sante 2008, 19(2):61-76.
43. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. Jama 2003, 289(5):579-588. PMID: 12578491
44. Garriguet D, Colley RC. A comparison of self-reported leisure-time physical activity and measured moderate-to-vigorous physical activity in adolescents and adults. Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la sante / Statistique Canada, Centre canadien d'information sur la sante 2014, 25(7):3-11.
45. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation 2011, 123(24):2870-2891. doi: 10.1161/CIRCULATIONAHA.110.968735PMID: 21690503
46. Garriguet D. Diet quality in Canada. Health Reports 2009, 20(3):41-52. PMID: 19813438
47. Manuel DG, Perez R, Bennett C, Rosella L, Taljaard M, Roberts M et al: Seven More Years: The impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario. In: An ICES/PHO Report. Toronto: Institute for Clinical Evaluative Sciences and Public Health Ontario; 2012.
48. Manuel DG, Perez R, Bennett C, Rosella L, Choi B. 900,000 Days in Hospital: The Annual Impact of Smoking, Alcohol, Diet, and Physical Activity on Hospital Use in Ontario. In. Toronto, ON: Institute for Clinical Evaluative Sciences; 2014.
49. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015, 350:g7594. doi: 10.1136/bmj.g7594PMID: 25569120
50. Taljaard M, Tuna M, Bennett C, Perez R, Rosella L, Tu JV et al: Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol. BMJ open 2014, 4(10):e006701. doi: 10.1136/bmjopen-2014-006701PMID: 25341454